The National Cardiovascular Health Program

The National Cardiovascular Health Program is a federally funded initiative administered by the Centers for Disease Control and Prevention (CDC), specifically under the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP). This program operates under the authority of Section 317(a) of the Public Health Service Act [42 USC 247b] and aligns with Assistance Listing 93.426, which is focused on improving the health of Americans through the prevention and management of diabetes, heart disease, and stroke. This funding opportunity reflects a broader commitment by the CDC to strengthen evidence-based public health interventions and address persistent disparities in cardiovascular disease outcomes across diverse populations, especially those at highest risk. The primary objective of this funding opportunity is to implement and evaluate evidence-based strategies aimed at the prevention and management of cardiovascular disease (CVD), particularly in communities with high disease burden. This iteration of the National Cardiovascular Health Program includes a strong emphasis on addressing social determinants of health, recognizing that equitable access to preventive care and health systems responsive to social and economic conditions are critical to achieving optimal cardiovascular outcomes. The initiative encourages strategies that integrate clinical care, public health, and community-based efforts, creating synergistic models to reduce CVD risks. Eligibility for this funding is limited to state governments and their bona fide agents, including the District of Columbia, as per the governing statute. Local health departments and Tribal entities are not eligible under this Notice of Funding Opportunity (NOFO), as they are served under separate, specifically designated programs. This ensures alignment with congressional intent, as articulated in recent House Appropriations Reports, which direct enhanced resources to support, strengthen, and expand current evidence-based initiatives at the state level. Emphasis is placed on addressing cardiovascular health in women, particularly women of color, and underserved communities with limited access to care or information. The award will be administered as a cooperative agreement, with approximately 51 awards expected. The total estimated program funding is $275 million, with individual awards ranging from a minimum of $850,000 to a maximum of $2,000,000. There is no matching or cost-sharing requirement for applicants. This financial support is intended to enable recipients to deliver comprehensive and sustainable public health strategies that integrate surveillance, health equity approaches, and quality improvement in clinical and community settings. Applications for this funding cycle were due by April 25, 2023, with electronic submissions required by 11:59 p.m. Eastern Time. While this funding round is closed, the NOFO indicates recurring support for such efforts, with congressional language supporting continued expansion and reinforcement of similar initiatives. The program does not specify a pre-application requirement such as a Letter of Intent or concept paper. For further information or technical assistance, applicants were directed to contact Rebekah Buckley at the CDC via the program email: [email protected]. Although the official application window for this cycle has passed, those interested in future funding cycles are encouraged to monitor the CDC website and Grants.gov for updates. Applicants were also encouraged to consult the funding table included in the full announcement for state-specific allocations.